Measurements of Frequency, Temperature, RF Field Dependent Surface Resistance Using Superconducting Half-Wave Cavity

A theory of surface resistance of superconductor was rigorously formulated by Bardeen, Cooper, Schrieffer more than 50 years ago. Since then the accelerator community has been used the theory as a guideline to improve the surface resistance of the superconducting cavity. It has been observed that the surface resistance is dependent on frequency, temperature and rf field strength, and surface preparation. To verify these dependences, a well-controlled study is required. Although many different types of cavities have been tested, the typical superconducting cavities are built for specific frequencies of their application. They do not provide data other than at its own frequency. A superconducting half wave cavity is a cavity that enables us to collect the surface resistance data across frequencies of interest for particle accelerators and evaluate preparation techniques. This paper will present the design of the half wave cavity, its electromagnetic mode characteristics and experimental results

Cryogenic Probe Station at Old Dominion University Center for Accelerator Science

With a growing effort in research and development of an alternative material to bulk Nb for a superconducting radiofrequency (SRF) cavity, it is important to have a cost effective method to benchmark new materials of choice. At Old Dominion University\u27s Center for Accelerator Science, a cryogenic probe station (CPS) will be used to measure the response of superconductor samples under RF fields. The setup consists of a closed-cycle refrigerator for cooling a sample wafer to a cryogenic temperature, a superconducting magnet providing a field parallel to the sample, and DC probes in addition to RF probes. The RF probes will extract a quality factor from a sample patterned in a coplanar waveguide resonator structure on a 2\u27 wafer. From the measured quality factor, the surface resistance and the penetration depth as a function of temperature and magnetic field will be calculated. This paper will discuss the design and measurement procedures of the current CPS setup

Investigation of the Surface Resistance of Niobium Between 325 MHz and 1300 MHz Using a Coaxial Half-wave Cavity

The Center for Accelerator Science at Old Dominion University has built a half-wave coaxial cavity (*) to measure the surface resistance of niobium as a function of frequency, temperature, rf field, preparation techniques, over a wide range of frequencies of interest for particle accelerators. The characteristics of the half-wave coaxial cavity provide these information on a same surface. The preliminary results showed clearly the frequency dependence of residual surface resistance (**). After establishing baseline, we have conducted a study of low temperature baking effect on the surface resistance under controlled environment. This paper will describe the details of the test procedure, results and we will explore underlying physics of the phenomenon. * H. Park et al., MOPB003, Proc. SRF2015, http://jacow.org/** H. Park et al., THPB080, Proc. SRF2017, http://jacow.org

Lessons learned from RF-Dipole Prototype Cavities for LHC High Luminosity Upgrade

The RF-Dipole Crabbing Cavity designed for the LHC High Luminosity Upgrade includes two higher order mode (HOM) couplers. One of the HOM couplers is an rf filter, which is a high pass filter designed to couple to the horizontal dipole modes and accelerating modes up to 2 GHz, while rejecting the fundamental operating mode at 400 MHz. The coupler consists of a high pass filter circuit where the rejection of the operating mode and transmission of HOMs are sensitive to dimensional deviations. An rf test box has been designed to measure the transmission of the rf filter in order to qualify the fabricated HOM coupler and to tune the coupler. This paper presents the measurements of the HOM coupler with the rf test box

Cryogenic Test Results of the SPS Prototype RF-Dipole Crabbing Cavity With Higher Order Mode Couplers

The rf-dipole crabbing cavity planned for the LHC High Luminosity Upgrade is designed to deliver a transverse kick of 3.34 MV; crabbing the proton beam in the horizontal plane. The proton beams of the LHC machine operating at 7 TeV each sets high impedance thresholds on the crabbing cavity systems. The rf-dipole crabbing cavity is designed with a two higher order mode couplers to suppress those HOMs. The first prototype of the HOM couplers are fabricated at Jefferson Lab. This paper reports the cryogenic test results of the HOM couplers with the SPS prototype rf-dipole cavity

Reduced carbon emission estimates from fossil fuel combustion and cement production in China.

Nearly three-quarters of the growth in global carbon emissions from the burning of fossil fuels and cement production between 2010 and 2012 occurred in China. Yet estimates of Chinese emissions remain subject to large uncertainty; inventories of China's total fossil fuel carbon emissions in 2008 differ by 0.3 gigatonnes of carbon, or 15 per cent. The primary sources of this uncertainty are conflicting estimates of energy consumption and emission factors, the latter being uncertain because of very few actual measurements representative of the mix of Chinese fuels. Here we re-evaluate China's carbon emissions using updated and harmonized energy consumption and clinker production data and two new and comprehensive sets of measured emission factors for Chinese coal. We find that total energy consumption in China was 10 per cent higher in 2000-2012 than the value reported by China's national statistics, that emission factors for Chinese coal are on average 40 per cent lower than the default values recommended by the Intergovernmental Panel on Climate Change, and that emissions from China's cement production are 45 per cent less than recent estimates. Altogether, our revised estimate of China's CO2 emissions from fossil fuel combustion and cement production is 2.49 gigatonnes of carbon (2 standard deviations = ±7.3 per cent) in 2013, which is 14 per cent lower than the emissions reported by other prominent inventories. Over the full period 2000 to 2013, our revised estimates are 2.9 gigatonnes of carbon less than previous estimates of China's cumulative carbon emissions. Our findings suggest that overestimation of China's emissions in 2000-2013 may be larger than China's estimated total forest sink in 1990-2007 (2.66 gigatonnes of carbon) or China's land carbon sink in 2000-2009 (2.6 gigatonnes of carbon).This is the author accepted manuscript. The final version is available from NPG via http://dx.doi.org/10.1038/nature1467

Robust estimation of bacterial cell count from optical density

Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field